- Home
- PKE vs AUTL Comparison
PKE vs AUTL Comparison
Compare PKE & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- AUTL
- Stock Information
- Founded
- PKE 1954
- AUTL 2014
- Country
- PKE United States
- AUTL United Kingdom
- Employees
- PKE N/A
- AUTL N/A
- Industry
- PKE Military/Government/Technical
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PKE Industrials
- AUTL Health Care
- Exchange
- PKE Nasdaq
- AUTL Nasdaq
- Market Cap
- PKE 378.7M
- AUTL 433.8M
- IPO Year
- PKE N/A
- AUTL 2018
- Fundamental
- Price
- PKE $19.67
- AUTL $1.63
- Analyst Decision
- PKE
- AUTL Strong Buy
- Analyst Count
- PKE 0
- AUTL 5
- Target Price
- PKE N/A
- AUTL $9.12
- AVG Volume (30 Days)
- PKE 164.0K
- AUTL 2.9M
- Earning Date
- PKE 10-09-2025
- AUTL 11-13-2025
- Dividend Yield
- PKE 2.54%
- AUTL N/A
- EPS Growth
- PKE 5.81
- AUTL N/A
- EPS
- PKE 0.36
- AUTL N/A
- Revenue
- PKE $63,128,000.00
- AUTL $29,934,000.00
- Revenue This Year
- PKE N/A
- AUTL $641.63
- Revenue Next Year
- PKE N/A
- AUTL $109.21
- P/E Ratio
- PKE $54.64
- AUTL N/A
- Revenue Growth
- PKE 7.63
- AUTL 185.17
- 52 Week Low
- PKE $11.97
- AUTL $1.11
- 52 Week High
- PKE $21.52
- AUTL $4.69
- Technical
- Relative Strength Index (RSI)
- PKE 49.20
- AUTL 50.43
- Support Level
- PKE $19.43
- AUTL $1.51
- Resistance Level
- PKE $20.06
- AUTL $1.67
- Average True Range (ATR)
- PKE 0.81
- AUTL 0.09
- MACD
- PKE -0.15
- AUTL -0.01
- Stochastic Oscillator
- PKE 19.91
- AUTL 37.29
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.